Ready to take the decisive step in your business transmission?
Join our specialized marketplace and connect with qualified buyers or discover exceptional succession opportunities.
Join our specialized marketplace and connect with qualified buyers or discover exceptional succession opportunities.
This Swiss company specialising in medical devices represents a rare opportunity in the healthcare market. It designs, manufactures and markets injectable products based on hyaluronic acid for the medical sector, whilst holding regulatory authorisations to expand its portfolio into other medical device categories. The company also offers a high-end professional cosmetic range developed in-house. The complete on-site infrastructure enables control of the entire value chain, from research and development through to final packaging. The flagship products use advanced cross-linking technology ensuring prolonged duration of action, which constitutes a significant competitive advantage. The company holds all essential certifications to operate in the most demanding international markets, including several countries in the Middle East and Europe. The competitive pricing position, combined with recognised Swiss quality, opens interesting prospects for an ambitious buyer. The existing regulatory and operational capacity allows for the launch of new injectable or topical medical devices in promising areas such as anti-ageing, hair care or wound healing. The Swiss market, currently underexploited by the company, also represents immediate growth potential. The established international customer base, combined with available stock and ongoing production, ensures immediate business continuity. This opportunity is aimed at a buyer with strong commercial skills and management experience, capable of seizing development opportunities in existing and new markets. A unique opportunity to acquire a certified and operational structure in the dynamic medical devices sector, with significant diversification and expansion potential.
SwissMedic, ISO 13485 and CE MDR certifications guaranteeing access to the most demanding international markets Complete integrated infrastructure enabling research, production and packaging on a single site Proprietary long-lasting cross-linking technology offering a competitive advantage on injectable products Established commercial presence in several international markets with expansion potential in the Swiss market Regulatory and operational capacity to develop new medical devices in promising segments
Leez indexes this listing. Full details and the seller's contact are on the official listing.
View the official listingReference ID
102,395
Juridic form
SA (Public Limited Company)
Number of employees
6-20 employees
Published
September 21st, 2026
Don't miss the next opportunities
Create your buyer profile and set your criteria: every Thursday, we send you the new businesses that match them.
Free and no commitment